TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for Yuvvexy (TX-004HR)

BOCA RATON, Fla.--(BUSINESS WIRE)--Sep. 19, 2016-- TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women ’s healthcare company, today announced the acceptance of the NDA for Yuvvexy, the conditionally-approved trade name for TX-004HR, by the...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news